These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7211777)

  • 21. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
    Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L
    Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT demonstration of brain infarcts due to deep venous thrombosis in systemic lupus erythematosus.
    Shah ZR; Bellon EM; Toor AH; Shields R
    Comput Med Imaging Graph; 1988; 12(4):241-3. PubMed ID: 3179976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lupus coagulation inhibitor and venous thrombosis: a report of four cases.
    Williams H; Laurent R; Gibson T
    Clin Lab Haematol; 1980; 2(2):139-44. PubMed ID: 7398203
    [No Abstract]   [Full Text] [Related]  

  • 24. Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations.
    Pauzner R; Rosner E; Many A
    Acta Haematol; 1986; 76(2-3):90-4. PubMed ID: 3101369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic and hemorrhagic complications in children with the lupus anticoagulant.
    Bernstein ML; Salusinsky-Sternbach M; Bellefleur M; Esseltine DW
    Am J Dis Child; 1984 Dec; 138(12):1132-5. PubMed ID: 6439032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature.
    Grob JJ; Bonerandi JJ
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):211-9. PubMed ID: 3091656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
    Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A patient with systemic lupus erythematosus having IgA- and IgG-lupus anticoagulant and venous thrombosis].
    Okubo S; Yasunaga K; Egawa H; Murata K; Teraoka A
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):619-25. PubMed ID: 3122485
    [No Abstract]   [Full Text] [Related]  

  • 29. Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Averbuch M; Koifman B; Levo Y
    Am J Med Sci; 1987 Jan; 293(1):2-5. PubMed ID: 3101499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus Anticoagulant Positivity in Pediatric Patients With Prolonged Activated Partial Thromboplastin Time: A Single-Center Experience and Review of Literature.
    Malbora B; Bilaloglu E
    Pediatr Hematol Oncol; 2015; 32(7):495-504. PubMed ID: 26383899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Occurrence of lupus-type circulating anticoagulant in syphilis (author's transl)].
    Guillaume JC; Gouault-Heilmann M; Dumont MD; Touraine R
    Ann Dermatol Venereol; 1981; 108(2):139-43. PubMed ID: 7247216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
    Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary thromboembolism in a patient with circulating lupus anticoagulant].
    Rodríguez Pascual L; Martín Escudero JC; Carretero Sastre JL; Blanco Cabero JM; Tortosa Cavero JI
    Sangre (Barc); 1987; 32(4):506-11. PubMed ID: 3116688
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F
    BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thromboembolic manifestations in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Gazengel C; Tron F; Bach JF
    Ann Med Interne (Paris); 1980; 131(7):416-21. PubMed ID: 7224449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus.
    Manoharan A; Gibson L; Rush B; Feery BJ
    Aust N Z J Med; 1977 Aug; 7(4):422-6. PubMed ID: 270997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.